Chronic Myeloid Leukemia  >>  dexamethasone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dexamethasone / Generic mfg.
NCT00274820: Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder

Completed
2
15
US
ascorbic acid, vitamin C, arsenic trioxide, Trisenox®, ATO, dexamethasone, thalidomide, Thalomid®
Case Comprehensive Cancer Center
Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
09/07
10/07
NCT00199186: Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)

Checkmark Data
Dec 2010 - Dec 2010: Data
Unknown status
2
Europe
imatinib, vincristine, cyclophosphamide, cytosine arabinoside, dexamethasone, idarubicin, methotrexate (intrathecal), AraC (intrathecal), dexamethasone (intrathecal)
Johann Wolfgang Goethe University Hospital
Philadelphia Positive Acute Lymphoblastic Leukemia, Lymphoid Blastic Phase of Chronic Myeloid Leukemia
 
 

Download Options